Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)
SAN FRANCISCO and SUZHOU, China, May 16, 2025 /PRNewswire/ — Innovent Biologics,…
May 16, 2025
MindHYVE.ai™ and Alkhidmat Foundation Partner to Launch Pakistan's First Multi-Sector AI Initiative for Social Good
PESHAWAR, Pakistan, May 16, 2025 /PRNewswire/ — In a transformative move set to…
May 16, 2025
Moatable Reports First Quarter 2025 Financial Results
PHOENIX, May 16, 2025 /PRNewswire/ — Moatable, Inc. (OTC Pink: MTBLY) ("Moatable" or…
May 16, 2025
HOSKAR NIGHT PHNOM PENH 2025: CONNECTING INDUSTRY LEADERS TO EXPLORE CAMBODIA'S HOSPITALITY FUTURE.
HO CHI MINH CITY, Vietnam, May 16, 2025 /PRNewswire/ — Cambodia’s hospitality…
May 16, 2025
U Power Limited Announces Filing of 2024 Annual Report with the U.S. Securities and Exchange Commission
SHANGHAI, May 16, 2025 /PRNewswire/ — U Power Limited (Nasdaq: UCAR) (the…
